Exclusive coverage of The Uromigos Live & Unplugged, September 30 – October 1, 2022 ...
Conference Coverage
Coverage of the major medical conferences that impact genitourinary oncology professionals.
Advertisement
Coverage of the ASCO 2022 Annual Meeting
Coverage of the ASCO 2021 Annual Meeting
Coverage of the 2021 ASCO GU Symposium
Coverage of the 2022 ASCO GU Symposium
Coverage of AUA 2021
Coverage of AUA 2022
Coverage of ESMO 2022
Coverage of the SNMMI 2022 Meeting
Coverage of the SUO Annual Meeting 2021
Articles and coverage from The Uromigos Live & Unplugged
Advertisement
GU Oncology Now delivers the latest genitourinary oncology conference coverage, highlighting advancements in treatments and tech.
Get exclusive conference news straight to your inbox.
Knowledge Hub Spotlights
Curated clinical content based on conditions, therapies, and technologies
Roundtables
Clinical discussions with experts in the field
Panel experts discuss PSMA-targeting agents currently being assessed, including PSMA-I&T-Lutetium-177.
Dr. Oliver Sartor and Dr. Rana McKay discuss some limitations (and advantages) of lutetium-177-PSMA.
Dr. Oliver Sartor weighs in on lutetium-177-PSMA as an effective therapy for prostate cancer.
The palliative benefits of lutetium-177 PSMA are discussed, including reduced symptom burden compared with standard of care.
Drs. George and Sprenkle discuss PSMA PET scans, including challenges and the potential of Lutetium-based PSMA treatments.
The panel discusses lutetium-177-PSMA for the treatment of advanced prostate cancer and reviews the VISION trial.
Advertisement
Advertisement
